A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Clinical trial NCT03126695 · COMPLETED

Trial details

NCT number: NCT03126695
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2017-05-12
Primary completion: 2017-07-24
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.